BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 29178075)

  • 1. Metabolic Regulation in Mitochondria and Drug Resistance.
    Pan Y; Cao M; Liu J; Yang Q; Miao X; Go VLW; Lee PWN; Xiao GG
    Adv Exp Med Biol; 2017; 1038():149-171. PubMed ID: 29178075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer cell metabolism: Rewiring the mitochondrial hub.
    Oliveira GL; Coelho AR; Marques R; Oliveira PJ
    Biochim Biophys Acta Mol Basis Dis; 2021 Feb; 1867(2):166016. PubMed ID: 33246010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and the hallmarks of cancer.
    Giampazolias E; Tait SW
    FEBS J; 2016 Mar; 283(5):803-14. PubMed ID: 26607558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current and upcoming mitochondrial targets for cancer therapy.
    Kim HK; Noh YH; Nilius B; Ko KS; Rhee BD; Kim N; Han J
    Semin Cancer Biol; 2017 Dec; 47():154-167. PubMed ID: 28627410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxic enlarged mitochondria protect cancer cells from apoptotic stimuli.
    Chiche J; Rouleau M; Gounon P; Brahimi-Horn MC; Pouysségur J; Mazure NM
    J Cell Physiol; 2010 Mar; 222(3):648-57. PubMed ID: 19957303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria: The metabolic switch of cellular oncogenic transformation.
    Tan YQ; Zhang X; Zhang S; Zhu T; Garg M; Lobie PE; Pandey V
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188534. PubMed ID: 33794332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic reprogramming of mitochondrial respiration in metastatic cancer.
    Herst PM; Grasso C; Berridge MV
    Cancer Metastasis Rev; 2018 Dec; 37(4):643-653. PubMed ID: 30448881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of metabolism and tunneling nanotube-mediated intercellular mitochondria exchange in cancer drug resistance.
    Hekmatshoar Y; Nakhle J; Galloni M; Vignais ML
    Biochem J; 2018 Jul; 475(14):2305-2328. PubMed ID: 30064989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondria, Bioenergetics and Apoptosis in Cancer.
    Burke PJ
    Trends Cancer; 2017 Dec; 3(12):857-870. PubMed ID: 29198441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic reprogramming: the emerging concept and associated therapeutic strategies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2015 Oct; 34():111. PubMed ID: 26445347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mitochondrial Dynamics in Regulating the Unique Phenotypes of Cancer and Stem Cells.
    Chen H; Chan DC
    Cell Metab; 2017 Jul; 26(1):39-48. PubMed ID: 28648983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mitochondrial voltage-dependent anion channel 1 in tumor cells.
    Shoshan-Barmatz V; Ben-Hail D; Admoni L; Krelin Y; Tripathi SS
    Biochim Biophys Acta; 2015 Oct; 1848(10 Pt B):2547-75. PubMed ID: 25448878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of glycolysis in cancer cells: a novel strategy to overcome drug resistance associated with mitochondrial respiratory defect and hypoxia.
    Xu RH; Pelicano H; Zhou Y; Carew JS; Feng L; Bhalla KN; Keating MJ; Huang P
    Cancer Res; 2005 Jan; 65(2):613-21. PubMed ID: 15695406
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of targeting lonidamine liposomes that circumvent drug-resistant cancer by acting on mitochondrial signaling pathways.
    Li N; Zhang CX; Wang XX; Zhang L; Ma X; Zhou J; Ju RJ; Li XY; Zhao WY; Lu WL
    Biomaterials; 2013 Apr; 34(13):3366-80. PubMed ID: 23410681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The ATPase Inhibitory Factor 1 (IF1): A master regulator of energy metabolism and of cell survival.
    García-Bermúdez J; Cuezva JM
    Biochim Biophys Acta; 2016 Aug; 1857(8):1167-1182. PubMed ID: 26876430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic mutations affecting mitochondrial function in cancer drug resistance.
    Lee C; Park SH; Yoon SK
    Genes Genomics; 2023 Mar; 45(3):261-270. PubMed ID: 36609747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Friend or foe? Mitochondria as a pharmacological target in cancer treatment.
    Dickerson T; Jauregui CE; Teng Y
    Future Med Chem; 2017 Dec; 9(18):2197-2210. PubMed ID: 29182013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulated metabolism contributes to oncogenesis.
    Hirschey MD; DeBerardinis RJ; Diehl AME; Drew JE; Frezza C; Green MF; Jones LW; Ko YH; Le A; Lea MA; Locasale JW; Longo VD; Lyssiotis CA; McDonnell E; Mehrmohamadi M; Michelotti G; Muralidhar V; Murphy MP; Pedersen PL; Poore B; Raffaghello L; Rathmell JC; Sivanand S; Vander Heiden MG; Wellen KE;
    Semin Cancer Biol; 2015 Dec; 35 Suppl():S129-S150. PubMed ID: 26454069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in apoptosis, mitochondria and drug resistance in cancer cells.
    Indran IR; Tufo G; Pervaiz S; Brenner C
    Biochim Biophys Acta; 2011 Jun; 1807(6):735-45. PubMed ID: 21453675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer stem cell metabolism: a potential target for cancer therapy.
    Deshmukh A; Deshpande K; Arfuso F; Newsholme P; Dharmarajan A
    Mol Cancer; 2016 Nov; 15(1):69. PubMed ID: 27825361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.